Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
50%
Ph phase_2
1
17%
Ph phase_3
2
33%

Phase Distribution

3

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 21 (16.7%)
Phase 32 (33.3%)

Trials by Status

unknown350%
withdrawn117%
completed233%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnphase_1

Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas

NCT03920631
unknownphase_1

Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia

NCT04174586
completedphase_2

Microtransplantation in Older Patients With Acute Myeloid Leukemia

NCT02831192
unknownphase_3

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

NCT01484171
completedphase_1

Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes

NCT01674985
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03920631Phase 1

Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas

Withdrawn
NCT04174586Phase 1

Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia

Unknown
NCT02831192Phase 2

Microtransplantation in Older Patients With Acute Myeloid Leukemia

Completed
NCT01484171Phase 3

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Unknown
NCT01674985Phase 1

Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes

Completed
NCT02171117Phase 3

Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia

Unknown

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6